NewLimit is using epigenetic reprogramming to bring cells back to a younger and healthier state, thus tackling age related disease

Co-Founder & President Jacob Kimmel describes the science behind how this works, and the enormous amount of work that goes into choosing which transcription factors to target. The company is currently in IND enabling studies.